The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

RARE FINANCIAL STATEMENTS

Ultragenyx — balance sheet, income statement and cash flow trends

RAREUltragenyx

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-500 M0500 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue716.9 M $Gross Profit595.9 M $ · 83%Operating Income-528.9 M $ · -74%Pre-tax Income-582.5 M $ · -81%Net Income to Owners-586.4 M $ · -82%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue716.9 M $+17.5%
Gross Profit595.9 M $+14.5%
Operating Income-528.9 M $—
EBITDA-473 M $—
Net Income to Owners-586.4 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
01 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets1.3 B
  • Current Liabilities351 M $23%
  • Long-term Liabilities1.2 B $77%

Key Figures

YoY change
Total Assets1.3 B $-3.2%
Total Liabilities1.5 B $+34.8%
Total Equity-284 M $-287.7%
Cash & ST Investments292 M $-38.8%
Total Debt——
Net Debt-125 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-400 M-200 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-400 M-200 M0-485.3 M $Operating39.9 M $Investing397.2 M $Financing-48.1 M $Net Change

Key Figures

YoY change
Operating Cash Flow-485.3 M $—
Capital Expenditures4.2 M $-86.5%
Free Cash Flow-489.5 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on RARE

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.